Skip to main content

Table 1 Patient characteristics

From: Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery

 

Amiodarone (n = 11)

Control (n = 15)

p-values

Age, years (mean ± SD)

67.2 ± 7.5

71.7 ± 6.5

0.100

Men/Women, n

4/7

6/9

0.851

Cardiovascular comorbidity, n

  

 Valvular heart disease

8

13

 

 Ischemic heart disease

1

0

 

 Thoracic aortic aneurysm

1

0

 

 Aortic dissection

0

1

 

 Aortic dissection + Ischemic heart disease

1

0

 

 Valvular heart disease + Ischemic heart disease

0

1

 

Warfarin indication (preoperative), n

  

 Atrial fibrillation

4

11

 

 Post prosthetic valve replacement

4

4

 

 Low LVEF

3

0

 

Dosage of warfarin (baseline), mg/day (mean ± SD)

2.64 ± 0.89

3.07 ± 1.22

0.370

PT-INR value (baseline) (mean ± SD)

2.13 ± 0.58

2.27 ± 0.58

0.551

  1. LVEF left ventricular ejection fraction